account_balance
Investment manager · 13F filer · SEC CIK 1224962
Perceptive Advisors LLC
Reported value$6.44Bas of Jun 30, 2026
Positions102 23 new, 13 sold out
Top 10 weight49%PRAX alone is 11%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PRAX
Praxis Precision Medicines I
10.6%
SYRE
Spyre Therapeutics INC
6.0%Added
CELC
Celcuity INC
5.2%Added
ASND
Ascendis Pharma A/s
4.8%New
RYTM
Rhythm Pharmaceuticals INC
4.5%Added
ROIV
Roivant Sciences Ltd
4.4%Trimmed
RLAY
Relay Therapeutics INC
4.1%Added
TVTX
Travere Therapeutics INC
3.3%Trimmed
KARD
Kardigan INC
3.0%New
NUVL
Nuvalent INC
3.0%
92 others
51.1%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed
Biggest moves since Mar 31, 2026
remove_circleSold out
- Ascendis Pharma A/s $350M
- Centessa Pharmaceuticals PLC $209M
- Engene Holdings INC $39.7M
- Day One Biopharmaceuticals I $37.6M